Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled Study

Background. Previous studies used unequal or high daily dosages of methimazole (MMI) to compare the efficacy of once daily dose regimen (OD-MMI) with that of divided daily doses regimen (DD-MMI) in inducing euthyroidism. Objectives. To compare the efficacy of OD-MMI to that of DD-MMI using low daily...

Full description

Saved in:
Bibliographic Details
Main Authors: Sutin Sriussadaporn, Wanwaroon Pumchumpol, Raweewan Lertwattanarak, Tada Kunavisarut
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2017/2619695
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562575891496960
author Sutin Sriussadaporn
Wanwaroon Pumchumpol
Raweewan Lertwattanarak
Tada Kunavisarut
author_facet Sutin Sriussadaporn
Wanwaroon Pumchumpol
Raweewan Lertwattanarak
Tada Kunavisarut
author_sort Sutin Sriussadaporn
collection DOAJ
description Background. Previous studies used unequal or high daily dosages of methimazole (MMI) to compare the efficacy of once daily dose regimen (OD-MMI) with that of divided daily doses regimen (DD-MMI) in inducing euthyroidism. Objectives. To compare the efficacy of OD-MMI to that of DD-MMI using low daily dosage of MMI in inducing euthyroidism. Methods. Fifty patients with clinically nonsevere Graves’ hyperthyroidism were randomized to be treated with 15 mg/day OD-MMI or 15 mg/day DD-MMI. Results. 21 cases (84%) in OD-MMI and 23 cases (92%) in DD-MMI were eligible for analyses. During the treatment, there was no difference in baseline characteristics, serum FT3 and FT4 reductions, and cumulative rate of achieving euthyroidism (4.8% versus 4.3%, 28.6% versus 34.8%, 71.4% versus 82.6%, and 85.7% versus 87.0% at 2, 4, 8, and 12 weeks, resp.) between both regimens. Hypothyroidism developed in DD-MMI significantly more than in OD-MMI (17.4% versus 0%, p<0.05). Conclusions. Treatment with MMI at a low daily dosage of 15 mg/day OD-MMI is as effective as DD-MMI in the reduction of serum thyroid hormone levels and induction of euthyroidism. The OD-MMI regimen is preferable to the DD-MMI regimen in the treatment of clinically nonsevere Graves’ hyperthyroidism. This trial is registered with Thai Clinical Trials Registry: TCTR20170529001.
format Article
id doaj-art-f248460a7e804b21aa7f20705eb6453a
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-f248460a7e804b21aa7f20705eb6453a2025-02-03T01:22:20ZengWileyInternational Journal of Endocrinology1687-83371687-83452017-01-01201710.1155/2017/26196952619695Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled StudySutin Sriussadaporn0Wanwaroon Pumchumpol1Raweewan Lertwattanarak2Tada Kunavisarut3Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandDivision of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandDivision of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandDivision of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandBackground. Previous studies used unequal or high daily dosages of methimazole (MMI) to compare the efficacy of once daily dose regimen (OD-MMI) with that of divided daily doses regimen (DD-MMI) in inducing euthyroidism. Objectives. To compare the efficacy of OD-MMI to that of DD-MMI using low daily dosage of MMI in inducing euthyroidism. Methods. Fifty patients with clinically nonsevere Graves’ hyperthyroidism were randomized to be treated with 15 mg/day OD-MMI or 15 mg/day DD-MMI. Results. 21 cases (84%) in OD-MMI and 23 cases (92%) in DD-MMI were eligible for analyses. During the treatment, there was no difference in baseline characteristics, serum FT3 and FT4 reductions, and cumulative rate of achieving euthyroidism (4.8% versus 4.3%, 28.6% versus 34.8%, 71.4% versus 82.6%, and 85.7% versus 87.0% at 2, 4, 8, and 12 weeks, resp.) between both regimens. Hypothyroidism developed in DD-MMI significantly more than in OD-MMI (17.4% versus 0%, p<0.05). Conclusions. Treatment with MMI at a low daily dosage of 15 mg/day OD-MMI is as effective as DD-MMI in the reduction of serum thyroid hormone levels and induction of euthyroidism. The OD-MMI regimen is preferable to the DD-MMI regimen in the treatment of clinically nonsevere Graves’ hyperthyroidism. This trial is registered with Thai Clinical Trials Registry: TCTR20170529001.http://dx.doi.org/10.1155/2017/2619695
spellingShingle Sutin Sriussadaporn
Wanwaroon Pumchumpol
Raweewan Lertwattanarak
Tada Kunavisarut
Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled Study
International Journal of Endocrinology
title Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled Study
title_full Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled Study
title_fullStr Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled Study
title_full_unstemmed Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled Study
title_short Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled Study
title_sort efficacy of once daily versus divided daily administration of low daily dosage 15 mg day of methimazole in the induction of euthyroidism in graves hyperthyroidism a randomized controlled study
url http://dx.doi.org/10.1155/2017/2619695
work_keys_str_mv AT sutinsriussadaporn efficacyofoncedailyversusdivideddailyadministrationoflowdailydosage15mgdayofmethimazoleintheinductionofeuthyroidismingraveshyperthyroidismarandomizedcontrolledstudy
AT wanwaroonpumchumpol efficacyofoncedailyversusdivideddailyadministrationoflowdailydosage15mgdayofmethimazoleintheinductionofeuthyroidismingraveshyperthyroidismarandomizedcontrolledstudy
AT raweewanlertwattanarak efficacyofoncedailyversusdivideddailyadministrationoflowdailydosage15mgdayofmethimazoleintheinductionofeuthyroidismingraveshyperthyroidismarandomizedcontrolledstudy
AT tadakunavisarut efficacyofoncedailyversusdivideddailyadministrationoflowdailydosage15mgdayofmethimazoleintheinductionofeuthyroidismingraveshyperthyroidismarandomizedcontrolledstudy